Federal Court Dismisses Illumina Patent Infringement Suit against Affymetrix | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A US federal court has dismissed Illumina lawsuits alleging Affymetrix infringes on patents covering array technologies.

In a decision handed down on Tuesday, Judge Barbara Crabb of the US District Court for the Western District of Wisconsin granted summary judgment for Santa Clara, Calif.-based Affymetrix, saying the company does not infringe on US Patent numbers 7,510,841 and 7,612,020 and dismissed the cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.